Oxidative Stress in Idiopathic Non-Obstructive Azoospermia: Evidence, Measurement Constraints, and Implications for Antioxidant Pretreatment

Idiopathic non-obstructive azoospermia (iNOA) is heterogeneous and lacks established redox-directed treatment to improve sperm retrieval. This critical narrative review evaluates causal interpretation, biomarker validity, and antioxidant pretreatment. PubMed, Embase, Scopus, Web of Science, ClinicalTrials.gov, the World Health Organization registry platform, and ISRCTN were searched through 30 September 2026. Study-level appraisal separated population directness, measurement limitations, and outcome relevance. Most human evidence concerns mixed non-obstructive azoospermia (NOA), selected tissue phenotypes, or public datasets. Redox abnormalities accompany established spermatogenic failure, but human studies have not shown that they precede germ-cell loss. Disease associations and cell-composition effects have the strongest direct human support; an amplifier role is plausible, and a driver role is unproven. Observational melatonin exposure in 11 men was associated with tissue-marker differences, without clinical outcome data. Mechanistic, diagnostic, prognostic, and treatment-predictive evidence are distinct categories; neither preoperative redox prognosis nor treatment selection is clinically validated. No clearly eligible registry record explicitly designated sperm retrieval as the primary outcome of antioxidant pretreatment in rigorously characterized iNOA, although nonspecific endpoints and incomplete coverage limit this finding. Routine redox testing and empirical antioxidant pretreatment remain unsupported by direct clinical evidence. Progress requires reliable compartment-specific assays, independent validation, and randomized trials of sperm retrieval and safety.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-11-19
DOI
https://doi.org/10.3390/jcm15229063
Primary Topic
Sperm and Testicular Function
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Oxidative Stress in Idiopathic Non-Obstructive Azoospermia: Evidence, Measurement Constraints, and Implications for Antioxidant Pretreatment

Nikolaos Sofikitis, Fotios Dimitriadis, Vasileios Tzikoulis, Christos Roidos et al.
Journal of Clinical Medicine
Sperm and Testicular Function
article

Oxidative Stress in Idiopathic Non-Obstructive Azoospermia: Evidence, Measurement Constraints, and Implications for Antioxidant Pretreatment

Nikolaos Sofikitis, Fotios Dimitriadis, Vasileios Tzikoulis, Christos Roidos, Dung Mai Ba Tien, Aris Kaltsas, Nguyen Phuc Cam Hoang, Anastasios Anastasiadis, Tran Vinh Hung, Chrysanthos Chrysanthou
article en

Abstract

Idiopathic non-obstructive azoospermia (iNOA) is heterogeneous and lacks established redox-directed treatment to improve sperm retrieval. This critical narrative review evaluates causal interpretation, biomarker validity, and antioxidant pretreatment. PubMed, Embase, Scopus, Web of Science, ClinicalTrials.gov, the World Health Organization registry platform, and ISRCTN were searched through 30 September 2026. Study-level appraisal separated population directness, measurement limitations, and outcome relevance. Most human evidence concerns mixed non-obstructive azoospermia (NOA), selected tissue phenotypes, or public datasets. Redox abnormalities accompany established spermatogenic failure, but human studies have not shown that they precede germ-cell loss. Disease associations and cell-composition effects have the strongest direct human support; an amplifier role is plausible, and a driver role is unproven. Observational melatonin exposure in 11 men was associated with tissue-marker differences, without clinical outcome data. Mechanistic, diagnostic, prognostic, and treatment-predictive evidence are distinct categories; neither preoperative redox prognosis nor treatment selection is clinically validated. No clearly eligible registry record explicitly designated sperm retrieval as the primary outcome of antioxidant pretreatment in rigorously characterized iNOA, although nonspecific endpoints and incomplete coverage limit this finding. Routine redox testing and empirical antioxidant pretreatment remain unsupported by direct clinical evidence. Progress requires reliable compartment-specific assays, independent validation, and randomized trials of sperm retrieval and safety.

Journal of Clinical MedicineVol. 15(22)
University of Ioannina (GR), National and Kapodistrian University of Athens (GR), Aristotle University of Thessaloniki (GR), University General Hospital Attikon (GR), Bệnh viện Bình Dân (VN), University of Western Macedonia (GR)
Sperm and Testicular Function
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon